MHC Class II Molecules Enhance Toll-Like Receptor Mediated Innate Immune Responses

• Remo Frei ,

  * E-mail: remo.frei@kispi.uzh.ch (RF); roger.lauener@hgk.ch (RPL)

  Affiliation Division of Immunology/Allergology, University of Zurich, Children's Hospital, Zurich, Switzerland

  ⨯
• Johanna Steinle,

  Affiliation Division of Immunology/Allergology, University of Zurich, Children's Hospital, Zurich, Switzerland

  ⨯
• Thomas Birchler,

  Affiliation Section of Clinical Immunology, University Hospital Zurich, Zurich, Switzerland

  ⨯
• Susanne Loeliger,

  Affiliation Division of Immunology/Allergology, University of Zurich, Children's Hospital, Zurich, Switzerland

  ⨯
• Caroline Roduit,

  Affiliation Division of Immunology/Allergology, University of Zurich, Children's Hospital, Zurich, Switzerland

  ⨯
• Dirk Steinhoff,

  Affiliation Division of Immunology/Allergology, University of Zurich, Children's Hospital, Zurich, Switzerland

  ⨯
• Reinhart Seibl,

  Affiliation Division of Immunology/Allergology, University of Zurich, Children's Hospital, Zurich, Switzerland

  ⨯
• Katja Büchner,

  Affiliation Division of Immunology/Allergology, University of Zurich, Children's Hospital, Zurich, Switzerland

  ⨯
• Reinhard Seger,

  Affiliation Division of Immunology/Allergology, University of Zurich, Children's Hospital, Zurich, Switzerland

  ⨯
• Walter Reith,

  Affiliation Department of Pathology and Immunology, University of Geneva Medical School, Geneva, Switzerland

  ⨯
• Roger P. Lauener

  * E-mail: remo.frei@kispi.uzh.ch (RF); roger.lauener@hgk.ch (RPL)

  Affiliation Division of Immunology/Allergology, University of Zurich, Children's Hospital, Zurich, Switzerland

  ⨯